| |
| |
|
| Insider
Information: |
Mclaughlin Kevin F |
| Relationship: |
Director |
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
8,700 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$400,635 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
8,700 |
|
|
| Total
Value |
$400,635 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acceleron Pharma Inc |
XLRN |
SVP, CFO and Treasurer |
2021-11-19 |
0 |
2014-05-19 |
0 |
Premium* |
|
|
Vericel Corp |
VCEL |
|
2023-04-27 |
8,700 |
2020-04-29 |
0 |
Premium* |
|
|
Decibel Therapeutics, Inc. |
DBTX |
Director |
2023-09-25 |
0 |
2023-06-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DBTX |
Decibel Therapeutics, Inc... |
Director |
– • – |
2023-09-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,000) |
0 |
0 |
- |
|
| DBTX |
Decibel Therapeutics, Inc... |
|
• • – |
2023-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| VCEL |
Vericel Corp |
|
• • – |
2023-04-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,600 |
8,700 |
0 |
- |
|
| VCEL |
Vericel Corp |
|
– • – |
2022-04-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,600 |
6,100 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2021-11-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(10,681) |
0 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2021-09-24 |
4 |
OE |
$40.61 |
$218,251 |
D/D |
5,370 |
16,051 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2021-09-24 |
4 |
AS |
$160.38 |
$861,241 |
D/D |
(5,370) |
10,681 |
0 |
% |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2021-09-23 |
4 |
AS |
$160.26 |
$3,146,887 |
D/D |
(19,630) |
10,681 |
0 |
% |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2021-09-23 |
4 |
OE |
$30.17 |
$778,624 |
D/D |
19,630 |
30,311 |
0 |
- |
|
| VCEL |
Vericel Corp |
|
– • – |
2021-04-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,750 |
3,500 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2021-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
4,868 |
10,681 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2021-01-05 |
4 |
AS |
$120.43 |
$181,982 |
D/D |
(1,499) |
5,813 |
0 |
% |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2021-01-04 |
4 |
D |
$124.31 |
$77,569 |
D/D |
(624) |
10,592 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2021-01-04 |
4 |
AS |
$123.49 |
$406,992 |
D/D |
(3,280) |
7,312 |
0 |
% |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2020-12-14 |
4 |
AS |
$130.14 |
$5,534,594 |
D/D |
(42,528) |
11,216 |
0 |
% |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2020-12-14 |
4 |
OE |
$27.97 |
$1,373,159 |
D/D |
42,528 |
53,744 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2020-12-11 |
4 |
AS |
$125.00 |
$387,500 |
D/D |
(3,100) |
11,216 |
0 |
% |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2020-12-11 |
4 |
OE |
$41.20 |
$127,720 |
D/D |
3,100 |
14,316 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2020-12-10 |
4 |
AS |
$125.12 |
$62,560 |
D/D |
(500) |
11,216 |
0 |
% |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2020-12-10 |
4 |
OE |
$27.97 |
$16,792 |
D/D |
500 |
11,716 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2020-12-09 |
4 |
AS |
$125.03 |
$484,116 |
D/D |
(3,872) |
11,216 |
0 |
% |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2020-12-09 |
4 |
OE |
$27.97 |
$141,537 |
D/D |
3,872 |
15,088 |
0 |
- |
|
| VCEL |
Vericel Corp |
|
– • – |
2020-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,750 |
1,750 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2020-04-09 |
4 |
AS |
$88.19 |
$1,519,161 |
D/D |
(17,226) |
11,216 |
0 |
% |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2020-04-09 |
4 |
OE |
$41.20 |
$709,711 |
D/D |
17,226 |
28,442 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
